1.Scutellarin inhibitting BV-2 microglia-mediated neuroinflammation via the cyclic GMP-AMP synthase-stimulator of interferon gene pathway
Zhao-Da DUAN ; Li YANG ; Hao-Lun CHEN ; Teng-Teng LIU ; Li-Yang ZHENG ; Dong-Yao XU ; Chun-Yun WU
Acta Anatomica Sinica 2024;55(2):133-142
		                        		
		                        			
		                        			Objective To explore the effect of scutellarin on lipopolysaccharide(LPS)induced neuroinflammation in BV-2 microglia cells.Methods BV-2 microglia were cultured and randomly divided into 6 groups:control group(Ctrl),cyclic GMP-AMP synthetase(cGAS)inhibitor RU320521 group(RU.521 group),LPS group,LPS+RU.521 group,LPS+scutellarin pretreatment group(LPS+S)and LPS+S+RU.521 group.The expressions of cGAS,stimulator of interferon gene(STING),nuclear factor kappa B(NF-κB),phosphorylated NF-κB(p-NF-κB),neuroinflammatory factors PYD domains-containing protein 3(NLRP3)and tumor necrosis factor α(TNF-α)in BV-2 microglia were detected by Western blotting and immunofluorescent double staining(n= 3).Results Western blotting and immunofluorescent double staining showed that compared with the control group,the expression of cGAS,STING,p-NF-κB,NLRP3 and TNF-α in BV-2 microglia increased significantly after LPS induction(P<0.05),while the expression of cGAS,STING,p-NF-κB,NLRP3 and TNF-α in LPS+S group were significantly lower than those in LPS group(P<0.05).Treatment with cGAS pathway inhibitor RU.521 showed similar effects as the pre-treatment group with scutellarin.In addition,the change of NF-κB in each group was not statistically significant(P>0.05).Conclusion Scutellarin inhibits the neuroinflammation mediated by BV-2 microglia cells,which may be related to cGAS-STING signaling pathway.
		                        		
		                        		
		                        		
		                        	
2.Expert consensus on the prevention and treatment of adverse reactions in subcutaneous immunotherapy(2023, Chongqing).
Yu Cheng YANG ; Yang SHEN ; Xiang Dong WANG ; Yan JIANG ; Qian Hui QIU ; Jian LI ; Shao Qing YU ; Xia KE ; Feng LIU ; Yuan Teng XU ; Hong Fei LOU ; Hong Tian WANG ; Guo Dong YU ; Rui XU ; Juan MENG ; Cui Da MENG ; Na SUN ; Jian Jun CHEN ; Ming ZENG ; Zhi Hai XIE ; Yue Qi SUN ; Jun TANG ; Ke Qing ZHAO ; Wei Tian ZHANG ; Zhao Hui SHI ; Cheng Li XU ; Yan Li YANG ; Mei Ping LU ; Hui Ping YE ; Xin WEI ; Bin SUN ; Yun Fang AN ; Ya Nan SUN ; Yu Rong GU ; Tian Hong ZHANG ; Luo BA ; Qin Tai YANG ; Jing YE ; Yu XU ; Hua Bin LI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2023;58(7):643-656
3. Advances in research of polysaccharides on inflammatory diseases and gut microbiota
Yu-Zhe HUANG ; Qian-Zhen WU ; Hao CHEN ; Kun-Feng ZHANG ; Jie-Lin CHEN ; Yan CHEN ; Teng-Fei XU ; Da-Xiang LI
Chinese Pharmacological Bulletin 2022;38(11):1601-1606
		                        		
		                        			
		                        			 Gut microbiota is a bridge between the metabolism and health state of the host,which plays a very important role in maintaining homeostasis. Natural polysaccharides,widely existed in nature,are a kind of biological macromolecules with prebiotics effects,which can improve a degree of physiological status by selectively changing the gut microbiota structure and function,enhancing the content of short chain fatty acids(SCFAs)and decreasing the level of inflammatory cytokines. In addition,the majority of polysaccharides can be degraded by gut microbiota to enhance their bioavailability and to promote the health state of the host. In this paper we discuss the interaction among polysaccharides and gut microbiotanatural,degradation mechanism and review gut microbiota as a target in the treatment of metabolic diseases,so as to provide future prospects of natural polysaccharides as " prebiotics " functional factors in the field of biological medicine and health products. 
		                        		
		                        		
		                        		
		                        	
4.Three dimensional nephrometry system for partial nephrectomy: Our initial exploration.
Xin Fei LI ; Yi Ji PENG ; Xiao Teng YU ; Sheng Wei XIONG ; Si Da CHENG ; Guang Pu DING ; Kun Lin YANG ; Qi TANG ; Yue MI ; Jing Yun WU ; Peng ZHANG ; Jia Xin XIE ; Han HAO ; He WANG ; Jian Xing QIU ; Jian YANG ; Xue Song LI ; Li Qun ZHOU
Journal of Peking University(Health Sciences) 2021;53(3):613-622
		                        		
		                        			OBJECTIVE:
		                        			To construct a preoperative evaluation system for partial nephrectomy using CT three-dimensional visualization technology and to explore its practical value.
		                        		
		                        			METHODS:
		                        			The clinical data of the patients who underwent partial nephrectomy for renal tumors in Department of Urology, Peking University First Hospital were collected retrospectively. At the same time, the homogenized standard data of patients who underwent partial nephrectomy for renal tumors were collected in 16 clinical centers in China. The CT three-dimensional visualization system was applied (IPS system, Yorktal) to evaluate tumor anatomy, blood supply, perirenal fat and other information. The parameters were summarized to build a three-dimensional nephrometry system, on the basis of which virtual surgery design and intraoperative navigation were completed.
		                        		
		                        			RESULTS:
		                        			A three-dimensional visualization image was established based on the enhanced CT urography. The nephrometry system included the longest diameter and volume of the tumor, proportion volume of tumor invading the parenchyma, maximum depth of the tumor invading the parenchyma, contact surface area, flatness of the tumor surface, renal segment where the tumor was located, vascular variation, and perirenal fat. The average two-dimensional diameter of the tumor was (2.78±1.43) cm, the average three-dimensional maximum diameter was (3.09±1.35) cm, and the average postoperative pathological size was (3.01±1.38) cm. The maximum tumor diameter in the three-dimensional image was significantly related to the prolonged renal artery clamping time and intra-operative blood loss (r=0.502, P=0.020; r=0.403, P=0.046). The three-dimensional and pathological tumor volume were (25.7±48.4) cm3 and (33.0±36.4) cm3, respectively (P=0.229). The tumor volume was significantly related to the intraoperative blood loss (r=0.660, P < 0.001). The proportion volume of the tumor invading into renal parenchyma was significantly related to the prolongation of renal artery clamping and the occurrence of postoperative complications (r=0.410, P=0.041; r=0.587, P=0.005). The tumor contact surface area and the presence of vascular variation did not show correlation with the perioperative data and postoperative complications. While the preoperative evaluation was completed, the reconstructed three-dimensional image could be zoomed, rotated, combined display, color adjustment, transparency, and simulated cutting on the Touch Viewer system. The process generally consisted of showing or hiding the tissue, adjusting the transparency of the interested area, rotating and zooming the image to match the position of the surgical patient. Together, these functions met the requirements of preoperative virtual surgery plan and intraoperative auxiliary navigation.
		                        		
		                        			CONCLUSION
		                        			Three-dimensional images can provide a more intuitive anatomical structure. The CT three-dimensional visua-lization system clearly displays tumor anatomical parameters, blood supply and perirenal fat. The three-dimensional nephrometry system for renal tumors can help predict the difficulty of partial nephrectomy and perioperative complications. Importing the reconstructed three-dimensional visualization image into the specified program or robot operating system can complete virtual surgery and intraoperative navigation, helping the surgeon to better grasp the surgical process. The indexes included in the nephrometry system and the score weights of each index need to be confirmed and perfected by multi-center study with large samples.
		                        		
		                        		
		                        		
		                        			China
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kidney/surgery*
		                        			;
		                        		
		                        			Kidney Neoplasms/surgery*
		                        			;
		                        		
		                        			Laparoscopy
		                        			;
		                        		
		                        			Nephrectomy
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
5.Literature Research on Origin and Application of Classical Prescription Xiebaisan
Yu-li LI ; Teng-da YI ; Zhi-qiang TAN ; Yu LIANG ; Zhen-yi YUAN
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(4):168-174
		                        		
		                        			
		                        			Xiebaisan is one of the 100 classical prescriptions published by the state, and the research and development of its compound preparation has gradually become an upsurge. The research and development of classical prescriptions should start from the theory of traditional Chinese medicine and clinical practice, laying a solid foundation for research and development. Based on the above thinking, this study adopts the methods of traceability and bibliometrics to analyze the source, pathogenesis, efficacy, Fangyi and clinical application of Xiebaisan in order to further promote its literature research work. The results show that the origin of Xiebaisan can be traced back to the prescription of Xiefeitang in 
		                        		
		                        	
6.Relation Textual Research Between Effect Variation and Dosage of Famous Classical Formula Kaixinsan
Teng-da YI ; Yu-li LI ; Zhi-qiang TAN ; Rui-ling YANG ; Shun-kui GANG ; Zhen-yi YUAN
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(7):24-33
		                        		
		                        			
		                        			Kaixinsan recorded in an ancient medical book named 
		                        		
		                        	
7.Textual Research of Persicae Semen
Teng-da YI ; Meng-lin QIN ; Sha-sha WANG ; Li-ning LIU ; Zhen-yi YUAN ; Shun-kui GANG
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(8):142-150
		                        		
		                        			
		                        			Textual research on Chinese herbs is the preliminary work for the preparation of famous classical prescriptions. Through literature review,it was found that the researches of Persicae Semen focused on chemical compositions,pharmacological mechanism and medical record analysis in the recent years,and few researches based on the ancient literature were about the origin,concocting methods,flavor,meridian tropism,effects and indications. Textual research shows that the most commonly used names are Taoren and Taoheren,with a wide range of producing areas. The plant origin of Persicae Semen has not changed much since ancient times. Before the Qing dynasty,the plant origin of Persicae Semen was from the seeds of a kind of fruit named Shantao or Maotao,and in modern times,the seeds of 
		                        		
		                        	
8.Textual Research on Ancient and Modern Literature Analysis and Research of Classical Prescriptions for Shentong Zhuyutang
Teng-da YI ; Yu-li LI ; Yu LIANG ; Zhi-qiang TAN ; Lin-qiang NIU ; Shun-kui GANG ; Zhen-yi YUAN
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(2):28-36
		                        		
		                        			
		                        			The Shentong Zhuyutang is recorded in an ancient medical book named 
		                        		
		                        	
9.Textual Research on Ancient Literature of Classical Prescription Kaixinsan and Its Associated Prescription
Teng-da YI ; Yu-li LI ; Lin-qiang NIU ; Zhi-qiang TAN ; Rui-ling YANG ; Shun-kui GANG ; Zhen-yi YUAN
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(5):8-15
		                        		
		                        			
		                        			The classical prescription Kaixinsan,which is recorded in an ancient medical book named 
		                        		
		                        	
10.Therapeutic effect of PCI combined tirofiban hydrochloride on aged ASTEMI patients and its influence on cardiac function and myocardial microcirculation indexes
Qing-Xu WANG ; De-Cai LI ; Da-Yong ZHANG ; Bo HU ; Tao CHEN ; Zhi-Yuan ZHOU ; Chao-Hui LIU ; Huan-Jun TANG ; Yan YANG ; Teng HU ; Yun-Feng DI
Chinese Journal of cardiovascular Rehabilitation Medicine 2018;27(2):174-178
		                        		
		                        			
		                        			Objective:To explore therapeutic effect of percutaneous coronary intervention(PCI)combined tirofiban hydrochloride on aged patients with acute ST elevation myocardial infarction(ASTEMI)and its influence on cardiac function and myocardial microcirculation.Methods:A total of 90 aged ASTEMI patients undergoing PCI in our hospital from Jul 2013 to Mar 2016 were selected.According to hospitalization order,they were randomly and e-qually divided into pure PCI group and combined treatment group(received tirofiban based on pure PCI group), both groups were treated for one month.ST segment regression degree,corrected TIMI frame count(CTFC)and TIMI flow grade after PCI,contrast agent acoustic peak intensity in myocardial microcirculation(PI)and serum CK-MB peak concentration before and after PCI,LVEF,LVEDd and LVEDV before and six months after PCI, and incidence rate of adverse events were measured and compared between two groups.Results:Compared with pure PCI group after PCI,there were significant rise in ST segment regression degree[(43.8 ± 7.1)% vs.(66.2 ± 8.2)%],TIMI flow grade[(2.1 ± 0.5)grade vs.(2.9 ± 0.6)grade]and PI[(7.1 ± 1.1)vs.(8.6 ± 1.2)],and sig-nificant reductions in CTFC[(27.3 ± 8.0)frame vs.(18.9 ± 6.6)frame],and serum CK-MB peak level[(296.5 ± 58.1)U/L vs.(199.3 ± 32.4)U/L]in combined treatment group,P= 0.001 all.Compared with pure PCI group on six months after PCI,there was significant rise in LVEF[(54.2 ± 8.3)% vs.(61.1 ± 8.0)%],and signifi-cant reductions in LVEDd[(48.1 ± 7.7)mm vs.(41.3 ± 8.1)mm]and LVEDV[(85.4 ± 10.6)mm3vs.(80.2 ± 10.4)mm3]in combined treatment group,P<0.05 or <0.01.Total incidence rate of adverse events of com-bined treatment group was significantly lower than that of pure PCI group(8.89% vs.26.67%),P=0.001.Con-clusion:PCI combined tirofiban hydrochloride can significantly improve myocardial microcirculation and cardiac function with low incidence rate of cardiovascular adverse events.The mechanism may be related to improving effect of tirofiban hydrochloride on myocardial microcirculation.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail